MedTrace Logo

Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"

NCT04819477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 973

Last updated 2024-03-18

No results posted yet for this study

Summary

Lung cancer is the most frequently dianosed cancer worldwide. To date, no screening method has been able to establish itself as routinely recommended by the guidelines. In this prospective study with 1:1 randomized questioning using an Internet tool, physicians will be asked in 2 phases (before and after intervention with a fact box) about their assessment of the benefits and risks of lung cancer screening by thoracic computed tomography and about a potential intention to change referral behavior. Randomly assigned, half of the participants will receive the same information in addition to the fact box graphically presented as a Cates plot.

Conditions

Interventions

BEHAVIORAL

Fact box

All physicians surveyed receive a fact box with numerical information on the benefits and harms of chest CT as a screening method. In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.

BEHAVIORAL

Cates plot

In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.

Sponsors & Collaborators

  • Karl Landsteiner Institute for Lung Research and Pneumological Oncology

    lead OTHER

Principal Investigators

  • Georg-Christian Funk, MD · 2nd Medical Department with Pneumology

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-10-30
Completion
2021-10-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04819477 on ClinicalTrials.gov